Vaginal inserted estradiol pharmaceutical compositions and methods
US10835487B2 · kind B2 · utility
11Cited by
583References
6Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Mar 30, 2020 |
| Grant date | Nov 17, 2020 |
| Priority date | — |
| Expiry date | Mar 30, 2040 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K47/14
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
According to various embodiments of this disclosure, pharmaceutical compositions comprising solubilized estradiol are provided. In various embodiments, such compositions are encapsulated in soft capsules which may be vaginally inserted for the treatment of vulvovaginal atrophy.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.